Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19
Systematic Review and Meta-synthesis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 28, 2021
- Accepted in final form July 6, 2021
- First Published August 27, 2021.
Author Disclosures
- Giovanna S. Manzano, MD,
- Caleb R. S. McEntire, MD,
- Maria Martinez-Lage, MD,
- Farrah J. Mateen, MD, PhD and
- Spencer K. Hutto, MD
- Giovanna S. Manzano, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Caleb R. S. McEntire, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maria Martinez-Lage, MD,
NONE
NONE
NONE
(1) Journal of Neuropathology and Experimental Neurology, Editorial Board Member (2) PathologyOutlines.com, Editorial Board Member
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH R01NS093120-04, Transcriptional Control of Glioma Development, (PI Dahmane), 2017-2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Farrah J. Mateen, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Mateen has served as a consultant for Genentech and Horizon Therapeutics, unrelated to this project.
NONE
NONE
NONE
Dr. Mateen has participated in clinical trials funded by EMD Serono and Genentech and received an unrestricted research grant from Biogen, unrelated to this project.
Dr. Mateen has received research support from the National Institutes of Health, unrelated to this project.
NONE
Dr. Mateen has received research support from National Multiple Sclerosis Society, the Fondation Pierre Fabre, and iConquerMS unrelated to this project.
NONE
NONE
NONE
NONE
NONE
NONE
- Spencer K. Hutto, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Division of Neuroimmunology and Neuroinfectious Diseases (G.S.M., C.R.S.M., F.J.M., S.K.H.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and Department of Pathology (M.M.-L.), Massachusetts General Hospital, Boston, MA.
- Correspondence
Dr. Hutto shutto{at}emory.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.